Triple Therapy With Boceprevir Plus Peginterferon Alfa-2a/Ribavirin In A Real-Life Setting: Is It Possible To Achieve Svr Rates Comparable To Pivotal Trials?
Journal of Hepatology（2014）
关键词
boceprevir,alfa-2a/ribavirin,achieve svr rates comparable,pivotal trials,peginterferon,real-life
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要